SCHEMBL11965543

SCHEMBL11965543

c1ccc(-c2cccc(-c3cc(-c4cccc(-c5cccnc5)c4)cc(-c4cccc(-c5cccnc5)c4)c3)c2)nc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 8/20 0.73
GRM5 P41594 2/20 0.56
KMO O15229 1/20 0.54
CYP3A4 P08684 2/20 0.52
ALDH1A1 P00352 1/20 0.52
CYP1A2 P05177 1/20 0.52
MEN1 O00255 1/20 0.51
PSIP1 O75475 1/20 0.51
AXL P30530 1/20 0.51
MKNK1 Q9BUB5 1/20 0.51
MKNK2 Q9HBH9 1/20 0.51
NPC1 O15118 2/20 0.51
RAB9A P51151 2/20 0.51
TP53 P04637 1/20 0.51
PKM P14618 1/20 0.51
TSHR P16473 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
CYP19A1 P11511 2/20 0.50
CYP17A1 P05093 1/20 0.50
CYP11B1 P15538 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24492855 1.00 CYP2A6 (0.73) CYP2A6GRM5KMOCYP3A4ALDH1A1
SCHEMBL19670662 0.98 CYP2A6 (0.76) CYP2A6GRM5KMOCYP3A4ALDH1A1
SCHEMBL5528966 0.97 CYP2A6 (0.69) CYP2A6GRM5KMOCYP3A4ALDH1A1
SCHEMBL21168167 0.97 CYP2A6 (0.73) CYP2A6GRM5KMOCYP3A4ALDH1A1
SCHEMBL24492849 0.94 CYP2A6 (0.65) CYP2A6GRM5KMOCYP3A4ALDH1A1
SCHEMBL24493079 0.94 CYP2A6 (0.65) CYP2A6GRM5KMOCYP3A4ALDH1A1
SCHEMBL18134294 0.93 CYP2A6 (0.69) CYP2A6GRM5KMOCYP3A4ALDH1A1
SCHEMBL18134274 0.93 CYP2A6 (0.69) CYP2A6GRM5KMOCYP3A4ALDH1A1
SCHEMBL14297299 0.93 CYP2A6 (0.69) CYP2A6GRM5KMOCYP3A4ALDH1A1
SCHEMBL18650176 0.93 CYP2A6 (0.69) CYP2A6GRM5KMOCYP3A4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11764320-B2 Method for depositing a conductive coating on a surface OTI LUMIONICS INC. (CA) 2023-09-19 US disclosed
US-11764320-B2 Method for depositing a conductive coating on a surface OTI LUMIONICS INC. (CA) 2023-09-19 US disclosed
US-11532763-B2 Method for depositing a conductive coating on a surface OTI LUMIONICS INC. (CA) 2022-12-20 US disclosed
US-20210351307-A1 METHOD FOR DEPOSITING A CONDUCTIVE COATING ON A SURFACE OTI LUMIONICS INC. (CA) 2021-11-11 US disclosed
US-20200411763-A1 COMPOUND, DISPLAY PANEL, AND DISPLAY APPARATUS WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2020-12-31 US disclosed
US-20200339513-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2020-10-29 US disclosed
US-8242488-B2 Organic electroluminescent element, display device, and illuminating device KONICA MINOLTA HOLDINGS, INC. (JP) 2012-08-14 US disclosed
US-8242488-B2 Organic electroluminescent element, display device, and illuminating device KONICA MINOLTA HOLDINGS, INC. (JP) 2012-08-14 US disclosed
US-20100207105-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, AND ILLUMINATING DEVICE KONICA MINOLTA HOLDINGS, INC. (JP) 2010-08-19 US disclosed
US-20100207105-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, AND ILLUMINATING DEVICE KONICA MINOLTA HOLDINGS, INC. (JP) 2010-08-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200339513-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, CYP1A1 CYP2A6 84/4885GRM5 3218/4885KMO 1844/4885
US-20200411763-A1 COMPOUND, DISPLAY PANEL, AND DISPLAY APPARATUS OCIAD2, OCIAD1, DRD2 CYP2A6 832/4885GRM5 3795/4885KMO 1999/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.